Fabio Martinelli is the Director of the Gynecololgic Oncology Surgical Division at Humanitas Pio X and tenure-track Assistant Professor of Gynecology and Obstetrics at Humanitas University.
Former attending physician in the Department of Gynecologic Oncology at IRCCS Foundation - National Cancer Institute of Milan –Italy since 2012, when he graduated residency in Obstetrics and Gynecology from the University of Milan.
During his training attended at The University of Texas MD Anderson Cancer Center - Gynecologic Oncology and Reproductive Medicine Department, at the Department of Gynaecology and Gynaecological Oncology of Kliniken-Essen-Mitte and at the Universidad Autonoma of Madrid.
His area of interest are: Gynecological Oncology, Gynecologic Malignancies Treatment (cervical, endometrial, ovarian and vulvar cancer and pre-invasive disease), Minimally invasive surgery in ob/gyn (Laparoscopy, Hysteroscopy), Cytoreductive surgery, Surgical techniques in gynecology, Sentinel node procedures, Laser surgery, Oncofertility, Fertility preservation in gynecologic cancers, HPV and colposcopy.
He is a European Society of Gynaecological Oncology (ESGO) certified European Gynaecological Oncologist.
He was awarded the National Scientific Qualification for Associate and Full Professorship in Gynecology and Obstetric - Ministry of Education, University and Research (Italy)
He has been the 2021-2023 Italian National Representative (NATREP) at ENYGO (European Network of Young Gynaecologic Oncologists).
He is an Expert Evaluator EX2021D431400 at the European Commission Funding & Tenders and Member of the panel of Expert in Medical Devices at the European Commission (EU), since 2021.
He is an European Society of Gynaecological Oncology (ESGO) member, an AAGL member and a participant in the AAGL’s oncology special interest group, member of Mario Negri Gynecologic Oncology Group (MaNGO), and past member of the Multicenter Italian Trials in Ovarian Cancer and gynecologic malignancies (MITO) group and board member of the Italian Society of Gynecologic Oncology (SIOG).
He is Principal Investigator and investigator in several national and international research studies and protocols.
He has authored and co-authored more than 150 articles in peer-reviewed journals as well as various book chapters. He is a member of several editorial boards as well as a reviewer for indexed journals.